MetLife Capex To Revenue vs Current Deferred Revenue Analysis

MET Stock

USD 69.06 1.21 1.72%

MetLife financial indicator trend analysis is infinitely more than just investigating MetLife recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MetLife is a good investment. Please check the relationship between MetLife Capex To Revenue and its Current Deferred Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.

Capex To Revenue vs Current Deferred Revenue

Capex To Revenue vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MetLife Capex To Revenue account and Current Deferred Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between MetLife's Capex To Revenue and Current Deferred Revenue is -0.48. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of MetLife, assuming nothing else is changed. The correlation between historical values of MetLife's Capex To Revenue and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of MetLife are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Capex To Revenue i.e., MetLife's Capex To Revenue and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

-0.48

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from MetLife's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MetLife current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.At this time, MetLife's Enterprise Value Over EBITDA is comparatively stable compared to the past year. Enterprise Value Multiple is likely to gain to 21.48 in 2024, whereas Selling General Administrative is likely to drop slightly above 5.8 B in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	71.1B	69.9B	66.4B	52.8B
Total Revenue	71.1B	69.9B	66.4B	52.8B

Gross Profit Total Revenue

MetLife fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Other Assets	Cash And Short Term Investments	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Other Liab	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Net Receivables	Good Will	Common Stock Total Equity	Short Term Investments	Inventory
Common Stock Shares Outstanding		0.76	0.62	0.85	0.85	0.75	0.69	-0.12	-0.25	-0.22	0.39	-0.5	0.92	0.75	0.08	-0.47	-0.23	-0.42	0.58	0.51	-0.16	0.42	0.56	0.09	0.41	0.66
Total Assets	0.76		0.77	0.5	0.49	0.82	0.4	0.51	0.35	-0.13	0.7	-0.2	0.85	1.0	0.24	-0.85	0.15	-0.3	0.47	0.27	0.1	0.73	0.89	0.62	0.7	0.17
Short Long Term Debt Total	0.62	0.77		0.44	0.44	0.54	0.69	0.29	0.18	-0.16	0.16	-0.04	0.68	0.78	0.57	-0.66	-0.07	-0.27	0.01	-0.04	0.57	0.66	0.88	0.43	0.16	0.19
Other Current Liab	0.85	0.5	0.44		1.0	0.43	0.74	-0.29	-0.43	-0.13	0.18	-0.56	0.81	0.49	-0.09	-0.15	-0.42	-0.32	0.57	0.67	-0.15	0.33	0.31	-0.08	0.19	0.88
Total Current Liabilities	0.85	0.49	0.44	1.0		0.43	0.74	-0.29	-0.43	-0.13	0.17	-0.57	0.81	0.49	-0.09	-0.14	-0.42	-0.32	0.57	0.67	-0.15	0.33	0.3	-0.08	0.19	0.88
Total Stockholder Equity	0.75	0.82	0.54	0.43	0.43		0.33	0.26	0.19	-0.42	0.6	-0.58	0.81	0.79	0.17	-0.58	0.14	-0.6	0.58	0.2	-0.19	0.37	0.67	0.34	0.61	0.35
Net Debt	0.69	0.4	0.69	0.74	0.74	0.33		-0.31	-0.54	-0.33	-0.2	-0.43	0.66	0.4	0.33	-0.07	-0.61	-0.44	0.14	0.2	0.3	0.25	0.41	-0.17	-0.19	0.69
Retained Earnings	-0.12	0.51	0.29	-0.29	-0.29	0.26	-0.31		0.84	0.19	0.58	0.3	0.11	0.53	0.04	-0.66	0.62	0.17	0.14	-0.08	0.31	0.5	0.57	0.83	0.56	-0.54
Cash	-0.25	0.35	0.18	-0.43	-0.43	0.19	-0.54	0.84		0.15	0.55	0.34	-0.02	0.36	0.18	-0.61	0.7	0.16	-0.07	-0.27	0.19	0.42	0.47	0.78	0.52	-0.61
Other Assets	-0.22	-0.13	-0.16	-0.13	-0.13	-0.42	-0.33	0.19	0.15		-0.09	0.59	-0.35	-0.09	-0.37	0.0	0.45	0.96	-0.04	0.25	0.12	0.24	-0.28	0.11	-0.09	-0.33
Cash And Short Term Investments	0.39	0.7	0.16	0.18	0.17	0.6	-0.2	0.58	0.55	-0.09		-0.13	0.53	0.7	-0.09	-0.72	0.37	-0.2	0.52	0.28	-0.4	0.46	0.53	0.65	1.0	-0.09
Non Current Liabilities Total	-0.5	-0.2	-0.04	-0.56	-0.57	-0.58	-0.43	0.3	0.34	0.59	-0.13		-0.59	-0.15	0.05	-0.22	0.31	0.72	-0.56	-0.27	0.43	0.18	-0.05	0.3	-0.14	-0.81
Other Stockholder Equity	0.92	0.85	0.68	0.81	0.81	0.81	0.66	0.11	-0.02	-0.35	0.53	-0.59		0.83	0.14	-0.55	-0.16	-0.55	0.61	0.44	-0.12	0.5	0.72	0.28	0.53	0.62
Total Liab	0.75	1.0	0.78	0.49	0.49	0.79	0.4	0.53	0.36	-0.09	0.7	-0.15	0.83		0.24	-0.87	0.15	-0.26	0.44	0.27	0.13	0.76	0.89	0.64	0.7	0.15
Total Current Assets	0.08	0.24	0.57	-0.09	-0.09	0.17	0.33	0.04	0.18	-0.37	-0.09	0.05	0.14	0.24		-0.23	-0.32	-0.31	-0.66	-0.77	0.53	0.17	0.43	-0.01	-0.1	-0.1
Short Term Debt	-0.47	-0.85	-0.66	-0.15	-0.14	-0.58	-0.07	-0.66	-0.61	0.0	-0.72	-0.22	-0.55	-0.87	-0.23		-0.4	0.1	-0.23	-0.11	-0.18	-0.73	-0.87	-0.82	-0.71	0.25
Other Liab	-0.23	0.15	-0.07	-0.42	-0.42	0.14	-0.61	0.62	0.7	0.45	0.37	0.31	-0.16	0.15	-0.32	-0.4		0.39	0.23	0.09	-0.08	0.22	0.16	0.6	0.36	-0.52
Accounts Payable	-0.42	-0.3	-0.27	-0.32	-0.32	-0.6	-0.44	0.17	0.16	0.96	-0.2	0.72	-0.55	-0.26	-0.31	0.1	0.39		-0.23	0.08	0.2	0.09	-0.39	0.04	-0.2	-0.49
Non Current Assets Total	0.58	0.47	0.01	0.57	0.57	0.58	0.14	0.14	-0.07	-0.04	0.52	-0.56	0.61	0.44	-0.66	-0.23	0.23	-0.23		0.85	-0.53	0.2	0.2	0.24	0.53	0.5
Non Currrent Assets Other	0.51	0.27	-0.04	0.67	0.67	0.2	0.2	-0.08	-0.27	0.25	0.28	-0.27	0.44	0.27	-0.77	-0.11	0.09	0.08	0.85		-0.43	0.25	0.01	0.13	0.3	0.52
Long Term Debt	-0.16	0.1	0.57	-0.15	-0.15	-0.19	0.3	0.31	0.19	0.12	-0.4	0.43	-0.12	0.13	0.53	-0.18	-0.08	0.2	-0.53	-0.43		0.29	0.35	0.2	-0.42	-0.26
Net Receivables	0.42	0.73	0.66	0.33	0.33	0.37	0.25	0.5	0.42	0.24	0.46	0.18	0.5	0.76	0.17	-0.73	0.22	0.09	0.2	0.25	0.29		0.69	0.76	0.46	-0.02
Good Will	0.56	0.89	0.88	0.31	0.3	0.67	0.41	0.57	0.47	-0.28	0.53	-0.05	0.72	0.89	0.43	-0.87	0.16	-0.39	0.2	0.01	0.35	0.69		0.71	0.52	0.01
Common Stock Total Equity	0.09	0.62	0.43	-0.08	-0.08	0.34	-0.17	0.83	0.78	0.11	0.65	0.3	0.28	0.64	-0.01	-0.82	0.6	0.04	0.24	0.13	0.2	0.76	0.71		0.63	-0.4
Short Term Investments	0.41	0.7	0.16	0.19	0.19	0.61	-0.19	0.56	0.52	-0.09	1.0	-0.14	0.53	0.7	-0.1	-0.71	0.36	-0.2	0.53	0.3	-0.42	0.46	0.52	0.63		-0.08
Inventory	0.66	0.17	0.19	0.88	0.88	0.35	0.69	-0.54	-0.61	-0.33	-0.09	-0.81	0.62	0.15	-0.1	0.25	-0.52	-0.49	0.5	0.52	-0.26	-0.02	0.01	-0.4	-0.08

Click cells to compare fundamentals

MetLife Account Relationship Matchups

MetLife fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	944.4M	913.2M	869.4M	808.9M	762.3M	954.7M
Total Assets	740.5B	795.1B	759.7B	666.6B	687.6B	656.2B
Short Long Term Debt Total	16.9B	18.1B	17.4B	18.0B	18.8B	18.1B
Other Current Liab	(235M)	(393M)	(341M)	(2.8B)	190M	180.5M
Total Current Liabilities	235M	393M	341M	217M	309M	293.6M
Total Stockholder Equity	66.1B	74.6B	67.5B	27.0B	30.0B	46.4B
Net Debt	253M	(1.6B)	(2.6B)	(2.2B)	(1.8B)	(1.7B)
Retained Earnings	33.1B	36.5B	41.2B	42.0B	40.1B	24.7B
Cash	16.6B	19.8B	20.0B	20.2B	20.6B	12.6B
Other Assets	8.6B	6.1B	(10.1B)	357.5B	373.7B	392.4B
Cash And Short Term Investments	348.3B	378.5B	367.5B	301.9B	308.1B	188.5B
Liabilities And Stockholders Equity	740.5B	795.1B	759.7B	666.6B	687.6B	656.2B
Non Current Liabilities Total	25.7B	28.8B	26.8B	639.1B	657.0B	689.9B
Other Stockholder Equity	20.0B	20.0B	15.4B	12.2B	9.1B	8.6B
Total Liab	674.1B	720.3B	692.0B	639.3B	657.3B	609.5B
Total Current Assets	368.7B	396.4B	384.8B	297.0B	302.1B	286.7B
Accumulated Other Comprehensive Income	13.1B	18.1B	10.9B	(27.1B)	(19.2B)	(18.3B)
Short Term Debt	268M	235M	393M	341M	119M	113.1M
Other Liab	548.5B	663.5B	633.0B	512.5B	589.3B	618.8B
Accounts Payable	363M	129M	2.2B	20.8B	18.7B	19.7B
Non Current Assets Total	363.1B	392.7B	385.0B	12.1B	11.8B	11.3B
Non Currrent Assets Other	(363.1B)	(392.7B)	(385.0B)	(309.3B)	(164.7B)	(173.0B)
Long Term Debt	4.1B	4.0B	17.1B	17.8B	18.7B	13.0B
Net Receivables	20.4B	17.9B	17.3B	17.5B	29.2B	18.7B
Good Will	9.3B	10.1B	9.5B	9.3B	9.2B	7.7B
Short Term Investments	331.7B	358.7B	347.5B	281.7B	287.5B	190.6B
Inventory	(62.4B)	(59.9B)	(55.4B)	(104.3B)	(93.9B)	(89.2B)
Treasury Stock	(12.7B)	(13.8B)	(18.2B)	(21.5B)	(19.3B)	(18.3B)
Intangible Assets	19.1B	18.7B	18.3B	25.5B	20.9B	12.2B
Property Plant Equipment	2.8B	2.6B	2.2B	1.9B	2.1B	1.5B
Property Plant And Equipment Net	354.0B	381.7B	375.3B	1.9B	(148.6B)	(141.2B)
Other Current Assets	62.4B	59.9B	55.4B	(22.4B)	69.1B	97.5B
Noncontrolling Interest In Consolidated Entity	238M	259M	267M	247M	284.1M	303.9M
Retained Earnings Total Equity	33.1B	36.5B	41.2B	42.0B	48.2B	30.2B
Deferred Long Term Liab	9.1B	11.0B	9.7B	325M	373.8M	355.1M
Net Tangible Assets	56.8B	64.4B	57.9B	17.7B	16.0B	15.2B

Pair Trading with MetLife

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MetLife position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MetLife will appreciate offsetting losses from the drop in the long position's value.

Moving together with MetLife Stock

0.66

FG Annuities Life

Pair Corr

The ability to find closely correlated positions to MetLife could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MetLife when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MetLife - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MetLife to buy it.

The correlation of MetLife is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MetLife moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MetLife moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for MetLife can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for MetLife Stock Analysis

When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC